Related Experiment Video
Updated: Dec 3, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
USP1 Regulates TAZ Protein Stability Through Ubiquitin Modifications in Breast Cancer
Ashley Mussell1, He Shen1, Yanmin Chen1
1Department of Cancer Genetics & Genomics, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14203, USA.
Abstract:
The Hippo signaling pathway is an evolutionarily conserved pathway that was initially discovered in Drosophila melanogaster and was later found to have mammalian orthologues. The key effector proteins in this pathway, YAP/TAZ, are often dysregulated in cancer, leading to a high degree of cell proliferation, migration, metastasis and cancer stem cell populations. Due to these malignant phenotypes it is important to understand the regulation of YAP/TAZ at the protein level. Using an siRNA library screen of deubiquitinating enzymes (DUBs), we identified ubiquitin specific peptidase 1 (USP1) as a novel TAZ (WWTR1) regulator. We demonstrated that USP1 interacts with TAZ and increases TAZ protein stability. Conversely, loss of function of USP1 reduces TAZ protein levels through increased poly-ubiquitination, causing a decrease in cell proliferation and migration of breast cancer cells. Moreover, we showed a strong positive correlation between USP1 and TAZ in breast cancer patients. Our findings facilitate the attainment of better understanding of the crosstalk between these pathways and may lead to potential therapeutic interventions for breast cancer patients.
Insights
Ubiquitin specific peptidase 1 (USP1) regulates TAZ protein stability, impacting breast cancer cell proliferation and migration. USP1 and TAZ show a positive correlation in patients, suggesting therapeutic potential.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- The Hippo signaling pathway, conserved from Drosophila to mammals, regulates cell growth and organ size.
- Key effectors YAP/TAZ are frequently dysregulated in cancers, promoting proliferation, migration, and metastasis.
- Understanding YAP/TAZ protein regulation is crucial for targeting cancer phenotypes.
Purpose of the Study:
- To identify novel regulators of TAZ (WWTR1) protein at the post-translational level.
- To investigate the role of deubiquitinating enzymes (DUBs) in TAZ regulation.
- To explore the therapeutic potential of targeting TAZ regulation in breast cancer.
Main Methods:
- Conducted an siRNA library screen targeting deubiquitinating enzymes (DUBs).
- Utilized co-immunoprecipitation to assess protein-protein interactions.
- Quantified protein levels, ubiquitination status, and cell proliferation/migration assays.
- Analyzed patient data for correlation between USP1 and TAZ expression.
Main Results:
- Identified ubiquitin specific peptidase 1 (USP1) as a novel regulator of TAZ.
- Demonstrated that USP1 interacts with TAZ and enhances its protein stability.
- USP1 depletion leads to increased TAZ poly-ubiquitination, reduced TAZ levels, and decreased breast cancer cell proliferation and migration.
- Observed a significant positive correlation between USP1 and TAZ expression in breast cancer patient samples.
Conclusions:
- USP1 deubiquitinase activity stabilizes TAZ protein, promoting malignant phenotypes in breast cancer.
- USP1-TAZ interaction represents a potential therapeutic target for breast cancer.
- Findings elucidate the crosstalk between USP1 and the Hippo pathway, offering insights for novel treatment strategies.
More Related Videos
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

